Navigation Links
Former FTC Attorney Christine White Joins Crowell & Moring's Health Care and Antitrust Groups
Date:1/30/2008

WASHINGTON, Jan. 30 /PRNewswire-USNewswire/ -- Crowell & Moring LLP is pleased to announce the addition of partner Christine L. White to its New York office as a member of the firm's Antitrust and Health Care groups. White joins from Bingham McCutchen LLP, where she helped found and co-chair the firm's Healthcare Industry Group. White is also a former staff attorney for the Federal Trade Commission (FTC), where she investigated and prosecuted mergers, joint ventures, and conduct cases involving health care entities. White's extensive experience in antitrust counseling and litigation will augment the firm's premier Health Care and Antitrust groups.

"Chris offers clients the in-depth experience that comes from working as both a government antitrust enforcer and trusted advisor to many of America's leading health care providers and payors. The combination of her public and private health care antitrust experience positions her to handle critical transactions and represent clients in government investigations and complex private litigation," said John T. Brennan, Jr., chair of Crowell & Moring's Health Care Group.

White concentrates her practice on antitrust counseling, antitrust civil litigation, and trade regulation matters. She provides counseling on a range of antitrust issues, including mergers, joint ventures and other collaborations among competitors in diverse industries. She has represented corporate, trade association and health care industry clients, such as local and national health care systems, multi-institutional systems, hospital districts, third party payors, provider network organizations, physician groups, and long-term care facilities. She also has represented medical device and pharmaceutical companies.

"Crowell & Moring offers my clients the opportunity to draw from among the largest and most esteemed health care and antitrust legal practices in the country. Health care clients require highly focused counsel from a
'/>"/>

SOURCE Crowell & Moring LLP
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Former Sufferer of Rare Disease Called Musicogenic Epilepsy Thanks LIJ Medical Team That Ended Her Seizures and Gave Her Back the Gift of Music
2. Sharing Miracles Television Program Extends Reach Across America: First Episode Features Former White House Press Secretary Tony Snow
3. Presidential Candidate and Former Arkansas Governor Mike Huckabee to Be Keynote Speaker for Hope International Universitys Celebrate Hope Dinner at Disneyland(R) Hotel
4. Former NFL Star Tiki Barber and CURE Founder Susan Axelrod Speak Out About Epilepsy on TODAY Show
5. MedcomSoft appoints former U.S. presidential health advisor, James Haveman, to health Care advisory board
6. Former Texas Assistant Attorney General Pat OConnell Joins Baron & Budd, P.C., to Lead Whistleblower Litigation Practice
7. Brain patterns of former anorexics reveal clues to disorders lasting impact
8. InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
9. Puget Sound Komen for the Cure, Former First Lady Mona Locke, Washington Health Leaders and Breast Cancer Survivors Call for Action to Reduce States High Breast Cancer Incidence
10. Former Congressman Hyde Awarded Presidential Medal of Freedom While Receiving Medical Rehabilitation at Marianjoy
11. Statement by Bonnie J. Campbell, Former Attorney General of Iowa and Spokesperson for Atlantic Richfield Co., Millennium Holdings, LLC, NL Industries, Inc., and The Sherwin-Williams Company on the Jury Verdict Reached Today in the Thomas (Milwaukee) Case

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... A jury of 8 people in the Wester...woman $2,300,000 in pain and suffering for a medic...mes Tallman and Alicia Nocera of Thomas E. Crenney... the plaintiff, Vita Monestersky and against the U...ency total abdominal hysterectomy at age 18. , ...
(Date:11/8/2009)...ation,s largest network of Hispanic health advocat...eform in 2009 ,, WASHINGTON, Nov. 7 /PRNewswir...entatives showed they have heard the voice of Amer...re for America Act. Now the Senate must deliver, w...care reform," said Dr. Jane L. Delgado, President ...
(Date:11/8/2009)...alls for Swift Passage of H.R. 3961 to Secure the ...wswire-USNewswire/ -- Statement Attributable to: J...Association. ,, (Logo: http://www.newscom.com...hails the passage of the House health reform bill,...ients and physicians and calls for swift passage o...
(Date:11/8/2009)...ealth Care Vote Shows Who Sides With Working Famil..., Nov. 8 On the heels o...esentatives for a good, balanced health care refor...ing of how our state,s U.S. representatives voted ... Act. ,, The legislation, which passed Saturda...
(Date:11/7/2009)...SHINGTON, Nov. 7 Karen ...urance Plans (AHIP), released the following statem...alth plans strongly support comprehensive health c...sion by proposing a complete overhaul of how healt...posed guaranteed coverage, elimination of pre-exis...
Breaking Medicine News(10 mins):Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:AHIP Statement on House Passage of H.R. 3962 2
...ns Growthink to Raise $2 Million Dollars in ...S, June 18 Growthink, the leading Investment,Bank...ging and Middle,Market Enterprises, announced toda... by the Food, Beverage,Pharmaceutical and Health S...
...uray,Incorporated (Nasdaq: ARAY ), a global leade...t its president and chief executive officer, Euan ...Jefferies Healthcare,Conference on Thursday, June ...any,s Web site at, http://www.accuray.com . The we...
...itment to Securing Confidential Customer ...SKING RIDGE, N.J. and NEWPORT BEACH, Calif., June ...re technology solutions,serving nearly half of the...ybertrust Enterprise Certification., By meeting t...
... University, Gentag,Inc., and Science Applications...combined forces to develop a non-invasive method f...rs agreed to combine their,respective intellectual...ting products could eliminate the need for finger,...
...e Integrase(TM) assays used to study ... FRANCISCO, Calif., June 18 Monogram,Biosciences,...ompany has,signed an agreement with Gilead Science...tients for study,enrollment and help select drugs ...
...new Lumax 540 technologies together with BIOTRONIK...d patient management that,provides daily protectio... BIOTRONIK GmbH & Co KG, the pioneer in wireless ...es, which,includes implantable cardioverter defibr...
Other Medicine News:Health News:Pop! Technology Goes Growthink 2Health News:Accuray Incorporated's CEO to Speak at Jefferies Second Annual Healthcare Conference 2Health News:TriZetto Maintains Prestigious Verizon Business Security Certification for Sixth Consecutive Year 2Health News:TriZetto Maintains Prestigious Verizon Business Security Certification for Sixth Consecutive Year 3Health News:TriZetto Maintains Prestigious Verizon Business Security Certification for Sixth Consecutive Year 4Health News:No More Needles? Georgetown University Teams with Gentag and SAIC to Develop New Glucose Sensor Technology with Wireless Connection to Cell Phones 2Health News:No More Needles? Georgetown University Teams with Gentag and SAIC to Develop New Glucose Sensor Technology with Wireless Connection to Cell Phones 3Health News:Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies 2Health News:Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies 3Health News:Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies 4Health News:Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies 5Health News:Tomorrow's care today: Lumax 540 cardiac devices launched at Cardiostim 2Health News:Tomorrow's care today: Lumax 540 cardiac devices launched at Cardiostim 3
(Date:11/6/2009)..., DURHAM, N.C., Nov. 6 ...OXBO) today announced that a previously approved r...at the start of trading on Monday, Nov. 9, 2009 on...eutics, Inc. shares will trade under the new symbo...r, 69207P 20 9, when the split becomes effective. ...
(Date:11/6/2009)..., WILMINGTON, Mass., Nov. 6 /PRNewswire-FirstCall...: DUSA), a dermatology company that is developing ... (PDT) and other products focused on patients with... President and Chief Executive Officer, will prese...d Investor Summit 2009 on Tuesday, November 10, 20...
(Date:11/6/2009)..., OAKLAND, Calif., Nov. 6 Kaiser ...spitals (KFHP/H), and their subsidiaries reported ...billion for the quarter ended September 30, 2009, ...last year. Operating income in the third quarter w...hird quarter of last year. Net non-operating incom...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 2Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 3Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 4Skin disease patients show brain immunity to faces of disgust 55521 1Skin disease patients show brain immunity to faces of disgust 55521 2Small rodents encourage the formation of scrubland in Spain 9717 1Small rodents encourage the formation of scrubland in Spain 9717 2Beta blockers and stroke new insights into their use for older people 9715 1Beta blockers and stroke new insights into their use for older people 9715 2
..., CAMBRIDGE, Mass. and LONDON, Feb. 6 Idenix Phar...Kline (GSK) today announced the execution of a lic...ghts to IDX899. IDX899 is a novel non-nucleoside ...I clinical development being developed by Idenix f...ed to address the increasing prevalence of viral r...
..., Journal of American College of Cardiology publis...., Feb. 5 Boston Scientific Corporation (NYSE: ... U.S. Food and Drug Administration (FDA) the final...) applications for both its TAXUS(R) Liberte(R) At...d its TAXUS Liberte Long(TM) Paclitaxel-Eluting Co...
Other Medicine Technology:Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV 2Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV 3Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV 4Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV 5Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 2Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 3Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 4Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 5
Dodick-Kammann Nucleus Chopper
Chang Phaco Chopper
Denman Brown Nucleus Cracker
Forceps Epilation Angled End B510.10 3.5"
Medicine Products: